Executive Stock‑Option Grants Signal Confidence in Cellectar Biosciences’ Future Growth
Executive option grants at Cellectar Biosciences reveal leadership confidence, hinting at a potential rebound to its 52‑week high of $6.52.
3 minutes to read
CELLECTAR BIOSCIENCES INC